tiprankstipranks
Trending News
More News >
Crescent Capital BDC (CCAP)
NASDAQ:CCAP
Advertisement

Crescent Capital BDC (CCAP) AI Stock Analysis

Compare
374 Followers

Top Page

CCAP

Crescent Capital BDC

(NASDAQ:CCAP)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
$15.50
▲(6.46% Upside)
Crescent Capital BDC's overall score is supported by strong financial performance and attractive valuation, particularly the high dividend yield. However, technical indicators suggest limited upward momentum, and challenges highlighted in the earnings call, such as NAV decline and tariff impacts, pose risks. The cautiously optimistic sentiment from the earnings call balances these factors.
Positive Factors
Strong Dividend Coverage
Stable dividend coverage reflects effective income management and provides a reliable income stream, enhancing investor confidence in the company's financial health.
Portfolio Stability and Risk Management
Improved non-accrual rates demonstrate effective risk management and portfolio stability, ensuring sustained income generation and reduced credit risk.
Strong Private Credit Platform
The active private credit platform supports growth opportunities and enhances the company's ability to generate attractive returns through strategic reinvestments.
Negative Factors
Net Asset Value Decline
A decline in NAV indicates potential weaknesses in asset valuation and could affect investor perception and future capital raising efforts.
Tariff Impact on Investments
Tariff-related challenges highlight vulnerability to external economic factors, potentially affecting future profitability and investment stability.
Potential Earnings Pressure
Earnings pressure from a lower rate environment could reduce income generation, impacting the company's ability to maintain current dividend levels.

Crescent Capital BDC (CCAP) vs. SPDR S&P 500 ETF (SPY)

Crescent Capital BDC Business Overview & Revenue Model

Company DescriptionCrescent Capital BDC (CCAP) is a business development company focused on providing flexible financing solutions to middle-market companies across various sectors, including healthcare, technology, and consumer services. CCAP offers a range of financial products, including secured debt, equity investments, and structured finance solutions, aimed at supporting the growth and development of its portfolio companies while generating attractive returns for its investors.
How the Company Makes MoneyCrescent Capital BDC generates revenue primarily through interest income from its investments in debt securities, as well as through dividend income from equity investments in its portfolio companies. The company earns interest on loans provided to middle-market companies, which typically offer higher yields than traditional fixed-income investments. Additionally, CCAP may charge fees for structuring and managing loans, providing further revenue streams. The company also benefits from capital appreciation in its equity investments, which can enhance overall returns. Strategic partnerships and relationships with financial institutions and investment firms can facilitate access to new investment opportunities and enhance its market positioning, contributing to its overall earnings.

Crescent Capital BDC Earnings Call Summary

Earnings Call Date:Nov 12, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
The earnings call reflected a stable and strong performance in dividend coverage and investment management, with proactive risk management in place. However, challenges such as a decline in NAV and tariff impacts on specific investments present concerns. The overall sentiment is cautiously optimistic with a balanced view of positive and negative trends.
Q3-2025 Updates
Positive Updates
Strong Dividend Coverage
Net investment income of $0.46 per share was unchanged from the prior quarter, translating to a 9.5% annualized NII yield with 110% base dividend coverage.
Portfolio Stability and Risk Management
The investment portfolio remained consistent at $1.6 billion with a highly diversified portfolio of 187 companies. Non-accruals improved from 2.4% to 1.6%, indicating strong portfolio management.
Increase in New Investments
Gross deployment in the second quarter totaled $74 million, including $51 million in new platform investments, maintaining a focus on high-quality companies with strong credit profiles.
Strong Private Credit Platform
Crescent's private credit platform was active with over $6 billion of capital committed to new and add-on investments over the last twelve months, providing opportunities for attractive reinvestment.
Negative Updates
Net Asset Value Decline
Net asset value decreased from $19.55 to $19.28 per share due to unrealized and realized losses from certain portfolio companies impacted by tariffs.
Tariff Impact on Certain Investments
Two portfolio companies facing operating challenges due to tariff impacts accounted for $0.15 per share in unrealized losses.
Potential Earnings Pressure
Anticipation that a lower base rate environment may gradually reduce portfolio yields and place some pressure on net investment income.
Company Guidance
During the third quarter earnings call for Crescent Capital BDC, Inc., guidance highlighted a range of metrics and strategic insights. The company reported a net investment income (NII) of $0.46 per share, maintaining an annualized NII yield of 9.5%. Despite a modest decline in net asset value from $19.55 to $19.28 per share due to tariff-related losses, Crescent achieved 110% base dividend coverage. The portfolio was valued at $1.6 billion across 187 companies, with a heavy emphasis on first lien loans, accounting for 90% of the portfolio. The investment strategy focused on core and lower middle markets, yielding a stable weighted average yield of 10.4% on income-producing securities. With $1.1 per share in spillover income, Crescent is well-positioned to navigate potential rate-driven earnings pressures. The company declared a regular quarterly dividend of $0.42 per share, representing a 9.12% annualized yield. Looking ahead, Crescent anticipates leveraging a more accommodative rate environment to enhance portfolio growth and sustain dividend coverage, supported by a robust origination pipeline and strategic sponsor partnerships.

Crescent Capital BDC Financial Statement Overview

Summary
Crescent Capital BDC demonstrates strong profitability and a solid financial position with effective leverage management. However, the company faces challenges in sustaining revenue growth and consistent cash flow generation. The balance sheet remains a strength, with a positive equity trend despite past fluctuations.
Income Statement
65
Positive
Crescent Capital BDC exhibits a strong net profit margin, reflecting effective cost management. However, revenue growth has been inconsistent year-on-year, and EBIT margins show volatility, indicating challenges in maintaining steady operational efficiency.
Balance Sheet
70
Positive
The company maintains a solid equity position, highlighted by a healthy equity ratio. The debt-to-equity ratio is favorable due to the absence of debt in the latest period, reducing financial risk. Historical fluctuations in stockholders' equity suggest some instability in asset management.
Cash Flow
60
Neutral
Operating cash flow has seen improvement, but free cash flow growth is inconsistent. The operating cash flow to net income ratio is robust, indicating strong cash generation relative to earnings. However, historical volatility in cash flow from financing activities could pose risks.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue152.98M142.44M147.33M52.10M101.10M62.02M
Gross Profit48.46M83.50M92.46M23.17M84.93M48.60M
EBITDA37.29M74.74M84.11M16.50M87.28M55.40M
Net Income36.01M73.65M83.84M15.54M83.63M54.67M
Balance Sheet
Total Assets1.63B1.66B1.63B1.30B1.32B1.05B
Cash, Cash Equivalents and Short-Term Investments5.79M10.13M7.78M6.40M10.07M1.90M
Total Debt875.32M875.84M844.78M654.46M631.04M471.93M
Total Liabilities913.55M915.64M884.78M690.34M665.52M494.15M
Stockholders Equity714.08M740.64M742.59M612.54M652.28M560.00M
Cash Flow
Free Cash Flow37.09M82.75M61.81M58.38M28.45M-61.80M
Operating Cash Flow37.09M82.75M61.81M58.38M28.45M-61.80M
Investing Cash Flow12.09M-23.85M30.48M-30.43M-186.11M-106.30M
Financing Cash Flow-58.66M-43.47M-84.99M-34.41M166.32M63.22M

Crescent Capital BDC Technical Analysis

Technical Analysis Sentiment
Positive
Last Price14.56
Price Trends
50DMA
14.06
Positive
100DMA
14.34
Positive
200DMA
14.62
Negative
Market Momentum
MACD
0.06
Negative
RSI
60.08
Neutral
STOCH
91.24
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCAP, the sentiment is Positive. The current price of 14.56 is above the 20-day moving average (MA) of 13.94, above the 50-day MA of 14.06, and below the 200-day MA of 14.62, indicating a neutral trend. The MACD of 0.06 indicates Negative momentum. The RSI at 60.08 is Neutral, neither overbought nor oversold. The STOCH value of 91.24 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CCAP.

Crescent Capital BDC Risk Analysis

Crescent Capital BDC disclosed 71 risk factors in its most recent earnings report. Crescent Capital BDC reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Crescent Capital BDC Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Neutral
$472.87M8.2911.86%10.78%41.12%-40.68%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$555.84M5.6318.68%10.76%-45.46%134.73%
66
Neutral
$525.29M14.624.92%13.05%-20.18%-61.90%
58
Neutral
$509.05M-1.15%22.98%-91.81%78.46%
58
Neutral
$500.69M19.153.22%15.11%-11.01%-65.56%
54
Neutral
$376.76M11.516.83%16.72%-3.09%200.66%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CCAP
Crescent Capital BDC
14.56
-2.87
-16.47%
GLAD
Gladstone Capital
21.20
-3.51
-14.20%
GAIN
Gladstone Investment
13.94
1.58
12.78%
PNNT
Pennantpark Investment
5.74
-0.23
-3.85%
TCPC
BlackRock TCP Capital
6.14
-1.76
-22.28%
CION
CION Investment Corp
9.86
-0.08
-0.80%

Crescent Capital BDC Corporate Events

Private Placements and Financing
Crescent Capital BDC Secures $185 Million in Notes
Neutral
Nov 3, 2025

On October 30, 2025, Crescent Capital BDC, Inc. entered into a Fourth Supplement to Note Purchase Agreement with institutional investors for the issuance of $185 million in senior unsecured notes, due between 2029 and 2031. The proceeds from these notes are intended for repaying existing indebtedness and general corporate purposes, potentially impacting the company’s financial flexibility and investment capabilities.

The most recent analyst rating on (CCAP) stock is a Hold with a $15.50 price target. To see the full list of analyst forecasts on Crescent Capital BDC stock, see the CCAP Stock Forecast page.

Crescent Capital BDC’s Balanced Earnings Call Insights
Sep 1, 2025

Crescent Capital BDC, Inc. recently held its earnings call, where the sentiment was notably neutral. The company reported stable net investment income and strong dividend coverage, supported by a diversified portfolio. However, challenges such as a decrease in net asset value (NAV), an increased watch list, and constrained market conditions balanced out these positives.

Crescent Capital BDC, Inc. Reports Q2 2025 Earnings
Aug 15, 2025

Crescent Capital BDC, Inc. is a business development company focused on providing capital solutions to middle market companies, aiming to maximize total return for its stockholders through current income and capital appreciation.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 13, 2025